Search results for "Prostate cancer staging"

showing 2 items of 2 documents

Radiomics and Prostate MRI: Current Role and Future Applications

2021

Multiparametric prostate magnetic resonance imaging (mpMRI) is widely used as a triage test for men at a risk of prostate cancer. However, the traditional role of mpMRI was confined to prostate cancer staging. Radiomics is the quantitative extraction and analysis of minable data from medical images; it is emerging as a promising tool to detect and categorize prostate lesions. In this paper we review the role of radiomics applied to prostate mpMRI in detection and localization of prostate cancer, prediction of Gleason score and PI-RADS classification, prediction of extracapsular extension and of biochemical recurrence. We also provide a future perspective of artificial intelligence (machine …

Biochemical recurrencemedicine.medical_specialtyReviewlcsh:Computer applications to medicine. Medical informaticslcsh:QA75.5-76.95030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancer0302 clinical medicineRadiomicsProstatelocalmedicineRadiology Nuclear Medicine and imaginglcsh:PhotographyGleason scoreElectrical and Electronic EngineeringMultiparametric Magnetic Resonance ImagingFuture perspectivemedicine.diagnostic_testbusiness.industryMagnetic resonance imaginglcsh:TR1-1050prostate cancerartificial intelligencemultiparametric magnetic resonance imagingneoplasm recurrencemedicine.diseaseComputer Graphics and Computer-Aided Designprostate cancer; artificial intelligence; multiparametric magnetic resonance imaging; Gleason score; neoplasm recurrence; localmedicine.anatomical_structure030220 oncology & carcinogenesislcsh:R858-859.7lcsh:Electronic computers. Computer scienceComputer Vision and Pattern RecognitionRadiologyProstate cancer stagingbusiness
researchProduct

Is free/total PSA predictive of pathological stage and Gleason score in patients with prostate cancer and serum PSAor=10 ng/ml?

2005

<i>Introduction:</i> To evaluate whether percent free prostate-specific antigen (%-fPSA) could be predictive of pathological stage and Gleason score in patients with prostate cancer (PCa) and serum PSA of 10 ng/ml or less. <i>Materials and Methods:</i> In 100 patients with total PSA≤10 ng/ml who underwent radical retropubic prostatectomy as primary treatment of PCa, %-fPSA levels in organ-confined vs. non-organ-confined PCa and in patients with Gleason score ≤/>7 were compared. <i>Results:</i> 32 patients had an organ-confined and 68 a locally advanced PCa. Median %-fPSA level was 15%; Gleasonscore was <7 in 49 patients, equal to 7 in 40 and >7 i…

OncologyMalemedicine.medical_specialtybusiness.industryUrologyUrologyProstatic NeoplasmsMiddle AgedProstate-Specific Antigenurologic and male genital diseasesmedicine.diseaseProstate cancerAntigenInternal medicinemedicineHumansNeoplasm stagingIn patientProstate cancer stagingStage (cooking)businessPathologicalTotal psaAgedNeoplasm StagingUrologia internationalis
researchProduct